Home grown FMCG firm Emami has enetered into a partnership with German homoeopathic firm Hevert-Arzneimittel for manufacturing and marketing of select Hevert formulations in India.
Emami through its homoeopathy arms M Bhattacharyya & Co and King & Co (Homoeo Chemist) has forged alliance with the German firm Hevert-Arzneimittel for "distribution & marketing, GMP Consultancy and licence for manufacturing select Hevert formulations in India", the firm said. As per the pact, Hevert-Arzneimittel products will be available in 400 homoeopathy medicine retail outlets across diverse distribution channels.
Established in 1889, M. Bhattacharyya and King & Co was acquired by Emami Group in 2011. It is one of the leading player of Rs 1,500 crore homoeopathy pharma market which is growing 25 per cent annually.
Emami through its homoeopathy arms M Bhattacharyya & Co and King & Co (Homoeo Chemist) has forged alliance with the German firm Hevert-Arzneimittel for "distribution & marketing, GMP Consultancy and licence for manufacturing select Hevert formulations in India", the firm said. As per the pact, Hevert-Arzneimittel products will be available in 400 homoeopathy medicine retail outlets across diverse distribution channels.
Established in 1889, M. Bhattacharyya and King & Co was acquired by Emami Group in 2011. It is one of the leading player of Rs 1,500 crore homoeopathy pharma market which is growing 25 per cent annually.